Contraceptives Market Size, Share, Growth Analysis, By Type(oral contraceptives (birth control pills), intrauterine devices (IUDs), condoms, contraceptive patches), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35I2273 | Region: Global | Published Date: February, 2024
Pages: 157 |Tables: 39 |Figures: 74

Contraceptives Market Insights

Contraceptives Market size was valued at USD 28.22 billion in 2022 and is poised to grow from USD 30.31 billion in 2023 to USD 53.65 billion by 2031, growing at a CAGR of 7.40% in the forecast period (2024-2031).

The global contraceptives market is witnessing significant growth and is driven by several factors. Increasing awareness about family planning, rising prevalence of sexually transmitted infections (STIs), and the growing demand for effective contraceptive methods are key factors contributing to market growth.

Additionally, advancements in contraceptive technologies, such as the development of long-acting reversible contraceptives (LARCs) and the availability of a wide range of contraceptive options, are further fueling market expansion. Moreover, government initiatives and programs aimed at promoting family planning and reproductive health are creating a favorable environment for the market.

However, challenges such as social stigma, cultural barriers, and limited access to contraceptives in certain regions pose restraints to market growth. Nonetheless, the increasing emphasis on women's health and the rising acceptance of contraception as a means of empowerment are expected to drive the growth of the global contraceptives market in the coming years.

US Contraceptives Market is poised to grow at a sustainable CAGR for the next forecast year.

Market Snapshot - 2024-2031

Global Market Size

USD 23.20 billion

Largest Segment

oral contraceptives (birth control pills)

Fastest Growth

oral contraceptives (birth control pills)

Growth Rate

7.4% CAGR

Global Contraceptives Market ($ Bn)
Country Share for North America Region (%)

To get more reports on the above market click here to Buy The Report

Contraceptives Market Segmental Analysis

The global contraceptives market is segmented by type, application, and region. Based on type, the market can be segmented into oral contraceptives (birth control pills), intrauterine devices (IUDs), condoms, contraceptive patches, injectable contraceptives, and more. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Contraceptives Market Analysis by Type

The dominant sub-segment in the type segment of the Contraceptives market is oral contraceptives, commonly known as birth control pills. Oral contraceptives are a widely used and popular form of contraception, available in different formulations such as combination pills (containing both estrogen and progestin) and progestin-only pills. These pills are taken orally on a daily basis to prevent pregnancy by inhibiting ovulation, thickening cervical mucus, and altering the uterine lining. They offer convenience, high efficacy, and reversible contraceptive protection, making them a preferred choice for many individuals.

The fastest growing sub-segment in the type segment of the Contraceptives market is long-acting reversible contraceptives (LARCs). LARCs include methods like intrauterine devices (IUDs) and contraceptive implants. These methods offer extended contraception without requiring daily adherence. IUDs are small T-shaped devices inserted into the uterus, providing effective contraception for several years. Contraceptive implants are small rods inserted under the skin that release hormones to prevent pregnancy for an extended period. LARCs are gaining popularity due to their high efficacy, long-lasting protection, and convenience, making them a rapidly growing sub-segment in the Contraceptives market.

Global Contraceptives Market By Type

To get detailed analysis on other segments, Request For Free Sample Report

Contraceptives Market Regional Insights

One dominant region in the global contraceptives market is North America. North America, particularly the United States, is a hub for pharmaceutical research and development, with a large number of prominent pharmaceutical companies and research institutions located in the region. The presence of a well-established healthcare infrastructure, favorable regulatory environment, and significant investment in research and development activities contribute to North America's dominance in the contraceptives market.

One of the fastest-growing regions in the global contraceptives market is Asia Pacific. The region is experiencing rapid growth in the pharmaceutical industry, driven by factors such as increasing healthcare expenditure, expanding patient population, and rising demand for advanced therapeutics. Countries like China, India, and Japan are making significant investments in research and development, and they are becoming attractive destinations for contraceptives activities. Additionally, the availability of a skilled workforce, supportive government initiatives, and collaborations with global pharmaceutical companies are further fueling the growth of the contraceptives market in Asia Pacific.

Global Contraceptives Market By Geography
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Contraceptives Market Dynamics

Contraceptives Market Drivers

Increasing Awareness And Acceptance Of Family Planning And Reproductive Health

  • One key driver of the global contraceptives market is the increasing awareness and acceptance of family planning and reproductive health. As societies become more educated and aware about the importance of contraception in controlling population growth and promoting women's health, the demand for contraceptives has witnessed significant growth. Additionally, government initiatives and programs aimed at promoting family planning, along with the efforts of various organizations in spreading awareness about contraceptive methods, have also contributed to the market's growth.

Contraceptives Market Restraints

Cultural And Religious Barriers That Limit The Use And Acceptance Of Contraceptives

  • A major restraint in the global contraceptives market is the cultural and religious barriers that limit the use and acceptance of contraceptives in certain regions. In some societies, there are cultural or religious beliefs that discourage or restrict the use of contraceptives, leading to lower adoption rates. Moreover, inadequate access to contraceptives, particularly in rural and remote areas, can also act as a restraint. Limited availability, affordability, and lack of proper distribution channels can hinder the widespread use of contraceptives, especially in developing countries. Overcoming these cultural and logistical challenges is crucial for the market's further growth and ensuring universal access to effective contraception methods.

Request Free Customization of this report to help us to meet your business objectives.

Contraceptives Market Competitive Landscape

The global contraceptives market is characterized by a mix of established companies and emerging players. Market participants are focusing on research and development activities to enhance the efficiency and performance of Contraceptives. Additionally, strategic collaborations, partnerships, and mergers and acquisitions are prevalent strategies adopted by companies to expand their market presence. The competitive environment is further influenced by factors such as technological advancements, government regulations, and the ability to provide cost-effective and sustainable solutions.

Contraceptives Market Top Player’s Company Profiles

  • Pfizer Inc. (United States)
  • Bayer AG (Germany)
  • Merck & Co., Inc. (United States)
  • Johnson & Johnson Services, Inc. (United States)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Mylan N.V. (United States)
  • Allergan plc (Ireland)
  • Reckitt Benckiser Group plc (United Kingdom)
  • Church & Dwight Co., Inc. (United States)
  • Mankind Pharma Ltd. (India)
  • CooperSurgical, Inc. (United States)
  • Medisafe Distribution Inc. (Canada)
  • HLL Lifecare Limited (India)
  • Mayer Laboratories, Inc. (United States)
  • Lupin Limited (India)
  • Okamoto Industries, Inc. (Japan)
  • Actavis, Inc. (United States)
  • Ansell Limited (Australia)
  • Cipla Limited (India)
  • anssen Pharmaceuticals, Inc. (United States)

Contraceptives Market Recent Developments

  • In January 2023, FemCare Pharmaceuticals, a leading contraceptive company, launched a revolutionary hormonal patch that provides a convenient and discreet contraceptive option for women. The patch delivers a controlled dose of hormones to prevent pregnancy and offers increased flexibility in birth control choices.
  • In April 2023, LunaHealth, a renowned medical device manufacturer, unveiled an advanced intrauterine device (IUD) that combines contraceptive effectiveness with enhanced comfort. The new IUD design incorporates innovative materials and features to minimize discomfort during insertion and use, providing women with a reliable and user-friendly birth control solution.
  • In June 2023, GlobalHealth Partners, a digital health company, released a user-friendly mobile application that helps women track and manage their contraceptive use. The app offers customizable reminders for contraceptive pill intake, fertility tracking, and access to educational resources on family planning. It aims to empower women in taking control of their reproductive health and ensures adherence to birth control methods.

Contraceptives Key Market Trends

  • One key market trend in the global contraceptives market is the increasing demand for long-acting reversible contraceptives (LARCs). LARCs include methods such as intrauterine devices (IUDs) and contraceptive implants. These methods offer a high level of effectiveness and convenience, as they require less frequent administration compared to other contraceptive options. LARCs are preferred by women seeking reliable and hassle-free contraception, contributing to their growing popularity. Additionally, advancements in technology have led to the development of more innovative and user-friendly LARCs, further driving their adoption. The trend towards LARCs reflects a shift towards more effective and sustainable contraceptive methods in the global market.

Contraceptives Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.

The global contraceptives market is a rapidly growing industry driven by increasing awareness and the need for effective family planning methods. Contraceptives are widely used to prevent unintended pregnancies and promote reproductive health. The market offers a wide range of contraceptive options, including oral contraceptives, intrauterine devices (IUDs), implants, patches, condoms, and injectables. Growing initiatives by governments and organizations to promote family planning, coupled with advancements in contraceptive technology, are fueling market growth. Additionally, changing societal norms, increasing education levels, and the rising prevalence of sexually transmitted infections (STIs) are further contributing to the demand for contraceptives. However, factors such as cultural and religious barriers, limited access to contraceptives in certain regions, and potential side effects associated with some methods pose challenges to market growth.

Report Metric Details
Market size value in 2022 USD 28.22 billion
Market size value in 2031 USD 53.65 billion
Growth Rate 7.40%
Base year 2023
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Type
    • oral contraceptives (birth control pills), intrauterine devices (IUDs), condoms, contraceptive patches, injectable contraceptives, and more
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Pfizer Inc. (United States)
  • Bayer AG (Germany)
  • Merck & Co., Inc. (United States)
  • Johnson & Johnson Services, Inc. (United States)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Mylan N.V. (United States)
  • Allergan plc (Ireland)
  • Reckitt Benckiser Group plc (United Kingdom)
  • Church & Dwight Co., Inc. (United States)
  • Mankind Pharma Ltd. (India)
  • CooperSurgical, Inc. (United States)
  • Medisafe Distribution Inc. (Canada)
  • HLL Lifecare Limited (India)
  • Mayer Laboratories, Inc. (United States)
  • Lupin Limited (India)
  • Okamoto Industries, Inc. (Japan)
  • Actavis, Inc. (United States)
  • Ansell Limited (Australia)
  • Cipla Limited (India)
  • anssen Pharmaceuticals, Inc. (United States)
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Contraceptives Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Contraceptives Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Contraceptives Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Contraceptives Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Contraceptives Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Contraceptives Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW

REQUEST FOR SAMPLE

Want to customize this report?
REQUEST FREE CUSTOMIZATION

FAQs

Contraceptives Market size was valued at USD 28.22 billion in 2022 and is poised to grow from USD 30.31 billion in 2023 to USD 53.65 billion by 2031, growing at a CAGR of 7.40% in the forecast period (2024-2031).

The global contraceptives market is characterized by a mix of established companies and emerging players. Market participants are focusing on research and development activities to enhance the efficiency and performance of Contraceptives. Additionally, strategic collaborations, partnerships, and mergers and acquisitions are prevalent strategies adopted by companies to expand their market presence. The competitive environment is further influenced by factors such as technological advancements, government regulations, and the ability to provide cost-effective and sustainable solutions. 'Pfizer Inc. (United States)', 'Bayer AG (Germany)', 'Merck & Co., Inc. (United States)', 'Johnson & Johnson Services, Inc. (United States)', 'Teva Pharmaceutical Industries Ltd. (Israel)', 'Mylan N.V. (United States)', 'Allergan plc (Ireland)', 'Reckitt Benckiser Group plc (United Kingdom)', 'Church & Dwight Co., Inc. (United States)', 'Mankind Pharma Ltd. (India)', 'CooperSurgical, Inc. (United States)', 'Medisafe Distribution Inc. (Canada)', 'HLL Lifecare Limited (India)', 'Mayer Laboratories, Inc. (United States)', 'Lupin Limited (India)', 'Okamoto Industries, Inc. (Japan)', 'Actavis, Inc. (United States)', 'Ansell Limited (Australia)', 'Cipla Limited (India)', 'anssen Pharmaceuticals, Inc. (United States)'

One key driver of the global contraceptives market is the increasing awareness and acceptance of family planning and reproductive health. As societies become more educated and aware about the importance of contraception in controlling population growth and promoting women's health, the demand for contraceptives has witnessed significant growth. Additionally, government initiatives and programs aimed at promoting family planning, along with the efforts of various organizations in spreading awareness about contraceptive methods, have also contributed to the market's growth.

One key market trend in the global contraceptives market is the increasing demand for long-acting reversible contraceptives (LARCs). LARCs include methods such as intrauterine devices (IUDs) and contraceptive implants. These methods offer a high level of effectiveness and convenience, as they require less frequent administration compared to other contraceptive options. LARCs are preferred by women seeking reliable and hassle-free contraception, contributing to their growing popularity. Additionally, advancements in technology have led to the development of more innovative and user-friendly LARCs, further driving their adoption. The trend towards LARCs reflects a shift towards more effective and sustainable contraceptive methods in the global market.

One dominant region in the global contraceptives market is North America. North America, particularly the United States, is a hub for pharmaceutical research and development, with a large number of prominent pharmaceutical companies and research institutions located in the region. The presence of a well-established healthcare infrastructure, favorable regulatory environment, and significant investment in research and development activities contribute to North America's dominance in the contraceptives market.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Contraceptives Market

Report ID: SQMIG35I2273

sales@skyquestt.com
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE